Cormorant Asset Management, LP

OnKure Therapeutics, Inc. · 10% Owner

Cormorant Asset Management, LP is listed in public filings as 10 percent owner. This Cormorant Asset Management, LP insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include OnKure Therapeutics, Inc. (OKUR), EyePoint Pharmaceuticals, Inc. (EYPT), Bright Minds Biosciences Inc. (DRUG), and Corbus Pharmaceuticals Holdings, Inc. (CRBP). Investors use Cormorant Asset Management, LP's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Bright Minds Biosciences Inc.DRUG$9.8M109.3k sharesSellApr 28, 2026$89.50--